Balchem Financial Statements
NASDAQ: BCPCIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Balchem revenue and earnings
In fiscal 2025, Balchem generated $1.04 billion in revenue, up 8.8% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $154.8 million (+20.5% year over year), for a net margin of 14.9% versus a median of 12.0% in the prior 5 years. Gross margin was 35.7% (up from 35.3%) and operating margin 20.2%.
Diluted earnings per share came in at $4.75, up from $3.93. Over the last 5 fiscal years, BCPC's revenue has grown at a 8.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Balchem income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.04B | 953.68M | 922.44M | 942.36M | 799.02M | 703.64M | 643.71M | 643.68M | 594.79M | 553.20M |
| Revenue growth (YoY) | +8.75% | +3.39% | -2.11% | +17.94% | +13.56% | +9.31% | +0.00% | +8.22% | +7.52% | +0.13% |
| Cost of Revenue | 666.53M | 617.48M | 620.38M | 661.91M | 555.85M | 479.75M | 432.34M | 439.43M | 405.78M | 372.34M |
| Gross Profit | 370.63M | 336.21M | 302.06M | 280.45M | 243.17M | 223.90M | 211.37M | 204.25M | 189.01M | 180.86M |
| Operating Expenses | 161.31M | 153.30M | 142.86M | 135.26M | 115.67M | 112.75M | 108.81M | 97.15M | 92.11M | 90.02M |
| Research & Development | 18.51M | 16.79M | 15.05M | 12.19M | 13.52M | 10.33M | 11.38M | 11.59M | 9.30M | 7.33M |
| Selling, General & Admin | 142.80M | 136.50M | 127.81M | 123.07M | 102.15M | 102.42M | 97.44M | 85.56M | 82.80M | 82.70M |
| Operating Income | 209.33M | 182.91M | 159.19M | 145.19M | 127.50M | 111.15M | 102.55M | 107.10M | 96.90M | 90.84M |
| Interest Expense | — | — | — | — | — | — | — | — | 7.54M | 7.26M |
| Other Income (Expense) | -10.30M | -16.46M | -21.93M | -11.44M | -2.27M | -4.73M | -6.08M | -8.07M | -8.41M | -7.90M |
| Pretax Income | 199.03M | 166.45M | 137.26M | 133.75M | 125.23M | 106.42M | 96.48M | 99.03M | 88.49M | 82.93M |
| Income Tax | 44.19M | 37.98M | 28.72M | 28.38M | 29.13M | 21.79M | 16.81M | 20.46M | -1.58M | 26.96M |
| Net Income | 154.84M | 128.47M | 108.54M | 105.37M | 96.10M | 84.62M | 79.67M | 78.57M | 90.07M | 55.97M |
| Net Income growth (YoY) | +20.53% | +18.36% | +3.01% | +9.64% | +13.57% | +6.22% | +1.40% | -12.77% | +60.92% | -6.28% |
| EPS (Basic) | 4.80 | 3.97 | 3.38 | 3.29 | 2.98 | 2.63 | 2.48 | 2.45 | 2.83 | 1.78 |
| EPS (Diluted) | 4.75 | 3.93 | 3.35 | 3.25 | 2.94 | 2.60 | 2.45 | 2.42 | 2.79 | 1.75 |
| Shares Outstanding (Basic) | 32.27M | 32.33M | 32.11M | 32.02M | 32.22M | 32.18M | 32.14M | 32.09M | 31.84M | 31.52M |
| Shares Outstanding (Diluted) | 32.60M | 32.72M | 32.45M | 32.39M | 32.67M | 32.50M | 32.51M | 32.45M | 32.23M | 31.92M |
| EBITDA | 255.02M | 230.88M | 214.13M | 197.03M | 176.38M | 162.43M | 148.41M | 151.77M | 141.28M | 137.04M |
| Gross Margin | 35.74% | 35.25% | 32.75% | 29.76% | 30.43% | 31.82% | 32.84% | 31.73% | 31.78% | 32.69% |
| Operating Margin | 20.18% | 19.18% | 17.26% | 15.41% | 15.96% | 15.80% | 15.93% | 16.64% | 16.29% | 16.42% |
| Net Margin | 14.93% | 13.47% | 11.77% | 11.18% | 12.03% | 12.03% | 12.38% | 12.21% | 15.14% | 10.12% |
This table shows 10 annual periods of Balchem's income statement, from FY 2025 back to FY 2016, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BCPC's reporting calendar. What is a income statement?